Veradermics, Incorporated reports Q1 results

* Veradermics, Incorporated press release [https://seekingalpha.com/pr/20510669-veradermics-reports-first-quarter-2026-financial-results-and-highlights-recent-corporate-and] (MANE [https://seekingalpha.com/symbol/MANE]): Q1 Net Loss: Net loss was $27.2 million, for the first quarter of 2026, as compared to a net loss of $12.4 million for the first quarter of 2025
* Cash Position: Cash, cash equivalents, and marketable securities totaled $390.8 million as of March 31, 2026, reflecting net proceeds from the company’s upsized initial public offering completed in February 2026. Subsequent to March 31, 2026.

MORE ON VERADERMICS, INCORPORATED

* Veradermics: Positive VDPHL01 Data Strengthens Late-Stage Pipeline Thesis [https://seekingalpha.com/article/4895248-veradermics-positive-vdphl01-data-strengthens-late-stage-pipeline-thesis]
* Veradermics, Incorporated (MANE) Discusses Positive Topline Results from Phase 2/3 Study of VDPHL01 for Mild-to-Moderate Pattern Hair Loss Transcript [https://seekingalpha.com/article/4894606-veradermics-incorporated-mane-discusses-positive-topline-results-from-phase-2-3-study-of]
* Veradermics, Incorporated (MANE) Discusses Positive Topline Results from Phase 2/3 Study of VDPHL01 for Mild-to-Moderate Pattern Hair Loss - Slideshow [https://seekingalpha.com/article/4894613-veradermics-incorporated-mane-discusses-positive-topline-results-from-phase-2-3-study-of]
* Veradermics prices upsized $384M public offering and $30M private placement at $100/share [https://seekingalpha.com/news/4582445-veradermics-prices-upsized-384m-public-offering-and-30m-private-placement-at-100share]
* Veradermics announces launch of public offering [https://seekingalpha.com/news/4580315-veradermics-announces-launch-of-public-offering]